Healthy volunteers needed to test safety of new hives drug
NCT ID NCT07230418
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-stage study tests the safety of a new oral drug called HRS-3095 in 66 healthy adults aged 18-55. It measures how the drug moves through the body and its effects on certain enzymes. The goal is to gather safety data, not to treat any disease, which will help guide future research for chronic spontaneous urticaria (hives).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Frist Clinical Medicial College of Qingdao University
RECRUITINGQingdao, Shandong, 266555, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.